Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists
- Author
- TAHIROVIC, Yesim A1 ; GEBALLE, Matthew1 ; HONGJIE YUAN3 ; WILSON, Lawrence J1 ; KOTLOSKI, Robert4 ; MCNAMARA, James O4 ; DINGLEDINE, Raymond3 ; LIOTTA, Dennis C1 ; TRAYNELIS, Stephen F3 ; SNYDER, James P1 ; GRUSZECKA-KOWALIK, Ewa2 ; MYERS, Scott J3 ; LYUBOSLAVSKY, Polina3 ; LE, Phuong3 ; FRENCH, Adam3 ; IRIER, Hasan3 ; CHOI, Woo-Baeg2 ; EASTERLING, Keith3
[1] Department of Chemistry, Emory University, Atlanta, Georgia, United States
[2] FOB Synthesis, Inc., Emtech Bio (Emory University and Georgia Tech), Atlanta, Georgia, United States
[3] Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia, United States
[4] Department of Neurobiology, Duke University, Durham, North Carolina, United States - Source
Journal of medicinal chemistry (Print). 2008, Vol 51, Num 18, pp 5506-5521, 16 p ; ref : 79 ref
- CODEN
- JMCMAR
- ISSN
- 0022-2623
- Scientific domain
- Pharmacology drugs
- Publisher
- American Chemical Society, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Affinité Aminoalcool Animal Antagoniste Anticonvulsivant Dérivé du benzène Enantiomère Hydroxyéther In vitro In vivo Locomotion Modèle moléculaire Modèle électrostatique Modélisation Neuroprotecteur Rat Relation structure activité Récepteur NMDA Récepteur glutamate Souris Sulfonamide Sélectivité Voie intrapéritonéale MéthanesulfonamideN-[4-(3-[(3,4-dichlorophénéthyl)amino]-2-hydroxypropoxy)phényl] Propanolamine dérivé Sous-unité NMDA R2B Chlore Composé organique Mammalia Rodentia Vertebrata
- Keyword (en)
- Affinity Aminoalcohol Animal Antagonist Anticonvulsant Benzene derivatives Enantiomer Hydroxyether In vitro In vivo Locomotion Molecular model Electrostatic model Modeling Neuroprotective agent Rat Structure activity relation NMDA receptor Glutamate receptor Mouse Sulfonamide Selectivity Intraperitoneal administration Chlorine Organic compounds Mammalia Rodentia Vertebrata
- Keyword (es)
- Afinidad Aminoalcohol Animal Antagonista Anticonvulsivante Benceno derivado Enantiómero Hidroxieter In vitro In vivo Locomoción Modelo molecular Modelo electrostático Modelización Neuroprotector Rata Relación estructura actividad Receptor NMDA Receptor glutámato Ratón Sulfonamida Selectividad Vía intraperitoneal Cloro Compuesto orgánico Mammalia Rodentia Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B06 Anticonvulsants. Antiepileptics. Antiparkinson agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B09 Neurotransmitters. Neurotransmission. Receptors / 002B02B09E Glutamatergic system (aspartate and other excitatory aminoacids)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B10 Neuroprotective agent
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20687105
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1021/jm8002153 
https://dx.doi.org/10.1021/jm8002153
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1021\/jm8002153\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of medicinal chemistry (Print)\";s:9:\"\u0000*\u0000stitle\";s:21:\"J. med. chem. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"51\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"5506\";s:8:\"\u0000*\u0000epage\";s:4:\"5521\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-2623\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"TAHIROVIC\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Yesim A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"GEBALLE, Matthew\";i:1;s:12:\"HONGJIE YUAN\";i:2;s:18:\"WILSON, Lawrence J\";i:3;s:16:\"KOTLOSKI, Robert\";i:4;s:17:\"MCNAMARA, James O\";i:5;s:19:\"DINGLEDINE, Raymond\";i:6;s:16:\"LIOTTA, Dennis C\";i:7;s:20:\"TRAYNELIS, Stephen F\";i:8;s:15:\"SNYDER, James P\";i:9;s:22:\"GRUSZECKA-KOWALIK, Ewa\";i:10;s:14:\"MYERS, Scott J\";i:11;s:20:\"LYUBOSLAVSKY, Polina\";i:12;s:10:\"LE, Phuong\";i:13;s:12:\"FRENCH, Adam\";i:14;s:12:\"IRIER, Hasan\";i:15;s:14:\"CHOI, Woo-Baeg\";i:16;s:17:\"EASTERLING, Keith\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JMCMAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:85:\"Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:25:\"American Chemical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"16\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1021\/jm8002153\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of medicinal chemistry (Print)\";s:9:\"\u0000*\u0000stitle\";s:21:\"J. med. chem. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"51\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"5506\";s:8:\"\u0000*\u0000epage\";s:4:\"5521\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-2623\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"TAHIROVIC\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Yesim A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"GEBALLE, Matthew\";i:1;s:12:\"HONGJIE YUAN\";i:2;s:18:\"WILSON, Lawrence J\";i:3;s:16:\"KOTLOSKI, Robert\";i:4;s:17:\"MCNAMARA, James O\";i:5;s:19:\"DINGLEDINE, Raymond\";i:6;s:16:\"LIOTTA, Dennis C\";i:7;s:20:\"TRAYNELIS, Stephen F\";i:8;s:15:\"SNYDER, James P\";i:9;s:22:\"GRUSZECKA-KOWALIK, Ewa\";i:10;s:14:\"MYERS, Scott J\";i:11;s:20:\"LYUBOSLAVSKY, Polina\";i:12;s:10:\"LE, Phuong\";i:13;s:12:\"FRENCH, Adam\";i:14;s:12:\"IRIER, Hasan\";i:15;s:14:\"CHOI, Woo-Baeg\";i:16;s:17:\"EASTERLING, Keith\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JMCMAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:85:\"Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:25:\"American Chemical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"16\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1021\/jm8002153\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1021\/jm8002153\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of medicinal chemistry (Print)\";s:9:\"\u0000*\u0000stitle\";s:21:\"J. med. chem. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"51\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"5506\";s:8:\"\u0000*\u0000epage\";s:4:\"5521\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-2623\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"TAHIROVIC\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Yesim A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"GEBALLE, Matthew\";i:1;s:12:\"HONGJIE YUAN\";i:2;s:18:\"WILSON, Lawrence J\";i:3;s:16:\"KOTLOSKI, Robert\";i:4;s:17:\"MCNAMARA, James O\";i:5;s:19:\"DINGLEDINE, Raymond\";i:6;s:16:\"LIOTTA, Dennis C\";i:7;s:20:\"TRAYNELIS, Stephen F\";i:8;s:15:\"SNYDER, James P\";i:9;s:22:\"GRUSZECKA-KOWALIK, Ewa\";i:10;s:14:\"MYERS, Scott J\";i:11;s:20:\"LYUBOSLAVSKY, Polina\";i:12;s:10:\"LE, Phuong\";i:13;s:12:\"FRENCH, Adam\";i:14;s:12:\"IRIER, Hasan\";i:15;s:14:\"CHOI, Woo-Baeg\";i:16;s:17:\"EASTERLING, Keith\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JMCMAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:85:\"Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:25:\"American Chemical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"16\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1021\/jm8002153\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of medicinal chemistry (Print)\";s:9:\"\u0000*\u0000stitle\";s:21:\"J. med. chem. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"51\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"5506\";s:8:\"\u0000*\u0000epage\";s:4:\"5521\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-2623\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"TAHIROVIC\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Yesim A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"GEBALLE, Matthew\";i:1;s:12:\"HONGJIE YUAN\";i:2;s:18:\"WILSON, Lawrence J\";i:3;s:16:\"KOTLOSKI, Robert\";i:4;s:17:\"MCNAMARA, James O\";i:5;s:19:\"DINGLEDINE, Raymond\";i:6;s:16:\"LIOTTA, Dennis C\";i:7;s:20:\"TRAYNELIS, Stephen F\";i:8;s:15:\"SNYDER, James P\";i:9;s:22:\"GRUSZECKA-KOWALIK, Ewa\";i:10;s:14:\"MYERS, Scott J\";i:11;s:20:\"LYUBOSLAVSKY, Polina\";i:12;s:10:\"LE, Phuong\";i:13;s:12:\"FRENCH, Adam\";i:14;s:12:\"IRIER, Hasan\";i:15;s:14:\"CHOI, Woo-Baeg\";i:16;s:17:\"EASTERLING, Keith\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JMCMAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:85:\"Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:25:\"American Chemical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"16\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1021\/jm8002153\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:85:\"Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Journal of medicinal chemistry (Print)\";s:9:\"\u0000*\u0000stitle\";s:21:\"J. med. chem. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"51\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"5506\";s:8:\"\u0000*\u0000epage\";s:4:\"5521\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-2623\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"TAHIROVIC\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Yesim A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"GEBALLE, Matthew\";i:1;s:12:\"HONGJIE YUAN\";i:2;s:18:\"WILSON, Lawrence J\";i:3;s:16:\"KOTLOSKI, Robert\";i:4;s:17:\"MCNAMARA, James O\";i:5;s:19:\"DINGLEDINE, Raymond\";i:6;s:16:\"LIOTTA, Dennis C\";i:7;s:20:\"TRAYNELIS, Stephen F\";i:8;s:15:\"SNYDER, James P\";i:9;s:22:\"GRUSZECKA-KOWALIK, Ewa\";i:10;s:14:\"MYERS, Scott J\";i:11;s:20:\"LYUBOSLAVSKY, Polina\";i:12;s:10:\"LE, Phuong\";i:13;s:12:\"FRENCH, Adam\";i:14;s:12:\"IRIER, Hasan\";i:15;s:14:\"CHOI, Woo-Baeg\";i:16;s:17:\"EASTERLING, Keith\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JMCMAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:85:\"Enantiomeric Propanolamines as selective N-Methyl-D-aspartate 2B Receptor Antagonists\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:25:\"American Chemical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"16\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
